NPY receptors in human cancer: A review of current knowledge

Peptides

Volumn 28, Issue 2, 2007, Pages 419-425

  Körner, Meike ^a   Reubi, Jean Claude ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adrenal gland tumor; Breast carcinoma; Human cancer; NPY receptor; Receptor autoradiography; Renal cell carcinoma

Indexed keywords

CYTOTOXIC AGENT; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; RADIOISOTOPE;

ADRENAL CORTEX CARCINOMA; AUTORADIOGRAPHY; BREAST CARCINOMA; CANCER GROWTH; CELL PROLIFERATION; GENE EXPRESSION; GENE OVEREXPRESSION; HORMONE RELEASE; HUMAN; IN VITRO STUDY; KIDNEY CARCINOMA; NERVE FIBER; OVARY CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SYSTEMATIC REVIEW; TUMOR CELL; TUMOR SCINTISCANNING; TUMOR VASCULARIZATION;

BLOOD VESSELS; HUMANS; NEOPLASMS; RECEPTORS, NEUROPEPTIDE Y;

EID: 33846599762     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.08.037     Document Type: Review

References (33)

1. Bernet F., Bernard J., Laborie C., Montel V., Maubert E., and Dupouy J.P. Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors. Neurosci Lett 166 (1994) 109-112
2. Bevan J.S. Clinical review: the antitumoral effects of somatostatin analog therapy in acromegaly. J Clin Endocrinol Metab 90 (2005) 1856-1863
3. Bjellerup P., Theodorsson E., Jornvall H., and Kogner P. Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours. Br J Cancer 83 (2000) 171-176
4. Cavadas C., Silva A.P., Mosimann F., Cotrim M.D., Ribeiro C.A., Brunner H.R., et al. NPY regulates catecholamine secretion from human adrenal chromaffin cells. J Clin Endocrinol Metab 86 (2001) 5956-5963
5. Cohen P.S., Cooper M.J., Helman L.J., Thiele C.J., Seeger R.C., and Israel M.A. Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors. Cancer Res 50 (1990) 6055-6061
6. De Jong M., Valkema R., Van Gameren A., Van Boven H., Bex A., Van De Weyer E.P., et al. Inhomogeneous localization of radioactivity in the human kidney after injection of [(1 1 1)In-DTPA]octreotide. J Nucl Med 45 (2004) 1168-1171
7. deS Senanayake P., Denker J., Bravo E.L., and Graham R.M. Production, characterization, and expression of neuropeptide Y by human pheochromocytoma. J Clin Invest 96 (1995) 2503-2509
8. 2+ dependent modulation of Src/ERK1/2 phosphorylation. Gastroenterology 126 (2004) A750
9. Gehlert D.R. Introduction to the reviews on neuropeptide Y. Neuropeptides 38 (2004) 135-140
10. Gibril F., Reynolds J.C., Doppman J.L., Chen C.C., Venzon D.J., Termanini B., et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. Ann Intern Med 125 (1996) 26-34
11. Hejna M., Schmidinger M., and Raderer M. The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?. Ann Oncol 13 (2002) 653-668
12. Kitlinska J., Abe K., Kuo L., Pons J., Yu M., Li L., et al. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res 65 (2005) 1719-1728
13. Körner M., Waser B., and Reubi J.C. High expression of NPY receptors in tumors of the human adrenal gland and extraadrenal paraganglia. Clin Cancer Res 10 (2004) 8426-8433
14. Körner M., Waser B., and Reubi J.C. Neuropeptide Y receptor expression in human primary ovarian neoplasms. Lab Invest 84 (2004) 71-80
15. Körner M., Waser B., and Reubi J.C. Neuropeptide Y receptors in renal cell carcinomas and nephroblastomas. Int J Cancer 115 (2005) 734-741
16. Kwekkeboom D.J., Teunissen J.J., Bakker W.H., Kooij P.P., de Herder W.W., Feelders R.A., et al. Radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 23 (2005) 2754-2762
17. Langer M., Kratz F., Rothen-Rutishauser B., Wunderli-Allenspach H., and Beck-Sickinger A.G. Novel peptide conjugates for tumor-specific chemotherapy. J Med Chem 44 (2001) 1341-1348
18. 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents. Bioconjug Chem 12 (2001) 1028-1034
19. Lee E.W., Michalkiewicz M., Kitlinska J., Kalezic I., Switalska H., Yoo P., et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111 (2003) 1853-1862
20. Li Q., Johansson H., and Grimelius L. Innervation of human adrenal gland and adrenal cortical lesions. Virchows Arch 435 (1999) 580-589
21. Muller A.F., and Van Der Lely A.J. Pharmacological therapy for acromegaly: a critical review. Drugs 64 (2004) 1817-1838
22. Pitzel L., Jarry H., and Wuttke W. Effects of substance-P and neuropeptide-Y on in vitro steroid release by porcine granulosa and luteal cells. Endocrinology 129 (1991) 1059-1065
23. Rämö O.J., Balasubramaniam A., Sheriff S., Rogers D.H., McCullough P.J., and Bell Jr. R.H. Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells. Neuropeptides 15 (1990) 101-106
24. Reubi J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24 (2003) 389-427
25. Reubi J.C., Gugger M., and Waser B. Coexpressed peptide receptors in breast cancers as molecular basis for in vivo multireceptor tumor targeting. Eur J Nucl Med 29 (2002) 855-862
26. Reubi J.C., Gugger M., Waser B., and Schaer J.C. Y1-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Cancer Res 61 (2001) 4636-4641
27. Reubi J.C., Körner M., Waser B., Mazzucchelli L., and Guillou L. High expression of peptide receptors as a novel target in gastrointestinal stromal tumours. Eur J Nucl Med Mol Imag 31 (2004) 803-810
28. Ruscica M., Dozio E., Boghossian S., Bovo G., Martos Riano V., Motta M., et al. Activation of the Y1 receptor by neuropeptide y regulates the growth of prostate cancer cells. Endocrinology 147 (2006) 1466-1473
29. Shaw J.L., Gackenheimer S.L., and Gehlert D.R. Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding. J Chem Neuroanat 26 (2003) 179-193
30. Shorter N.A., and Pence J.C. Retinoic acid-induced regulation of neuropeptide Y receptor expression and function in the neuroepithelioma line SK-N-MC. J Pediatr Surg 32 (1997) 721-723
31. Wharton J., Gordon L., Byrne J., Herzog H., Selbie L.A., Moore K., et al. Expression of the human neuropeptide tyrosine Y1 receptor. Proc Natl Acad Sci USA 90 (1993) 687-691
32. Woltering E.A. Development of targeted somatostatin-based antiangiogenic therapy: a review and future perspectives. Cancer Biother Radiopharm 18 (2003) 601-609
33. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83 (1998) 187-195